New product intros (apalutamide, betrixaban, bictegravir/emtricitabine/tenofovir alafenamide fumarate (new combination), ertugliflozin, ertugliflozin/metformin hydrochloride (new combination), ertugliflozin/sitagliptin (new combination), nonacog beta pegol, plecanatide (new indication), semaglutide, synthetic human angiotensin II, tezacaftor/ivacaftor (new combination))
Keyword(s):
Keyword(s):
Keyword(s):